Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.
Sollena P, Vasiliki N, Kotteas E, Stratigos AJ, Fattore D, Orlandi A, Mannino M, Di Pumpo M, Fida M, Starace M, Apalla Z, Romano MC, Riganti J, Segura S, Martinez AF, Fabbrocini G, Sibaud V, Peris K, On Behalf Of The Eadv Task Force Dermatology For Cancer Patients. Sollena P, et al. Among authors: fabbrocini g. Cancers (Basel). 2023 Jul 18;15(14):3658. doi: 10.3390/cancers15143658. Cancers (Basel). 2023. PMID: 37509319 Free PMC article.
Chemotherapy and skin reactions.
Fabbrocini G, Cameli N, Romano MC, Mariano M, Panariello L, Bianca D, Monfrecola G. Fabbrocini G, et al. J Exp Clin Cancer Res. 2012 May 28;31(1):50. doi: 10.1186/1756-9966-31-50. J Exp Clin Cancer Res. 2012. PMID: 22640460 Free PMC article.
Prurigo nodularis and pembrolizumab: A therapeutic challenge.
Fattore D, Panariello L, Annunziata MC, Fabbrocini G. Fattore D, et al. Among authors: fabbrocini g. Eur J Cancer. 2019 Mar;110:8-10. doi: 10.1016/j.ejca.2019.01.012. Epub 2019 Feb 5. Eur J Cancer. 2019. PMID: 30735833 No abstract available.
770 results